fbpx
Consumer Law

The State of Arkansas Sues Several Drug Manufacturers Over High Insulin Prices

Arkansas on Wednesday sued several drug manufacturers and pharmacy benefit managers over the cost of insulin for diabetes, accusing the companies of conspiring to inflate the price of the medication.

The lawsuit filed in state court accuses manufacturers Novo Nordisk, Sanofi and Eli Lilly of conspiring with pharmacy benefit managers Express Scripts, Caremark and Optum and violating Arkansas’ deceptive trade practices law with the high insulin prices.

“For these Arkansas residents with diabetes, the physical, emotional, and financial tolls of paying such excessive prices for diabetes medications is devastating,” the lawsuit, filed by Attorney General Leslie Rutledge, said. “Unable to afford the drugs their doctors prescribe, many diabetics in Arkansas ration or under-dose their insulin, inject expired insulin, reuse needles, and starve themselves to control their blood sugars.”

 

Read the source article at Associated Press News

Leave a Review or Comment

Back to top button